https://iecure.com/wp-content/uploads/logo-tm.svg52280eallison/wp-content/uploads/iEcure_logo.pngeallison2021-12-01 19:29:062021-12-29 20:47:04Penn gene editing spinout iECURE just raised a $50M Series A
https://iecure.com/wp-content/uploads/cen-logo.svg52280eallison/wp-content/uploads/iEcure_logo.pngeallison2021-12-01 19:26:302021-12-29 21:00:35Jim Wilson launches liver disease gene-editing company iECURE with $50 million
https://iecure.com/wp-content/uploads/logo-fiercebiotech.svg52280eallison/wp-content/uploads/iEcure_logo.pngeallison2021-12-01 19:25:272021-12-29 21:02:46iECURE emerges with $50M to search for ‘holy grail’ and ‘untapped frontier’ of gene editing
/wp-content/uploads/iEcure_logo.png00eallison/wp-content/uploads/iEcure_logo.pngeallison2021-09-15 08:00:302022-05-10 20:08:16iECURE Appoints Brian Di Donato to Board of Directors
/wp-content/uploads/iEcure_logo.png00eallison/wp-content/uploads/iEcure_logo.pngeallison2021-09-15 08:00:072022-05-10 20:08:59iECURE Launches With $50 Million Series A Financing to Develop In Vivo Gene Insertion Approaches for Devastating Diseases
https://iecure.com/wp-content/uploads/endpoint-news.svg52280eallison/wp-content/uploads/iEcure_logo.pngeallison2021-09-09 08:00:552021-12-30 15:38:36The Tachi Yamada legacy tree continues to grow with a new gene editing biotech from Jim Wilson
https://iecure.com/wp-content/uploads/forbes_logo_white.svg50198David Anderson/wp-content/uploads/iEcure_logo.pngDavid Anderson2021-09-09 08:00:322025-01-30 18:04:24This Startup Just Raised $50 Million To Deliver Gene Therapies For Rare Diseases
